Anxiety-related behaviors in cholecystokinin-A, B, and AB receptor gene knockout mice in the plus-mazeMIYASAKA, Kyoko; KOBAYASHI, Satoru; KAWANAMI, Takako et al.Neuroscience letters. 2002, Vol 335, Num 2, pp 115-118, issn 0304-3940, 4 p.Article

Therapeutic potential of cholecystokinin receptor antagonists in CNS disordersSCHIANTARELLI, P.Pharmacological research. 1993, Vol 28, Num 1, pp 1-9, issn 1043-6618Article

Structure activity and dose-effect relationships of the antagonism of picrotoxin-induced seizures by cholecystokinin, fragments and analogues of cholecystokinin in miceKADAR, T; PENKE, B; TOTH, G et al.Neuropharmacology. 1983, Vol 22, Num 10, pp 1223-1229, issn 0028-3908Article

Pharmacological study on the mixed CCK8/DA meso-nucleus accumbens pathway: evidence for the existence of storage sites containing the two transmittersSTUDLER, J. M; REIBAUD, M; TRAMU, G et al.Brain research. 1984, Vol 298, Num 1, pp 91-97, issn 0006-8993Article

SPECIES AND TISSUE DISTRIBUTION OF CHOLECYSTOKININ/GASTRIN-LIKE SUBSTANCES IN SOME INVERTEBRATESLARSON BA; VIGNA SR.1983; GENERAL AND COMPARATIVE ENDOCRINOLOGY; ISSN 0016-6480; USA; DA. 1983; VOL. 50; NO 3; PP. 469-475; BIBL. 2 P.Article

BIOASSAY OF CHOLECYSTOKININGIANNOULIS EL; BARRY RE.1982; ; GUT; ISSN 0017-5749; GBR; DA. 1982; VOL. 23; NO 2; PP. 146-149; BIBL. 6 REF.Article

THE IMPORTANCE OF THE AMINO ACID IN POSITION 27 OF CHOLECYSTOKININ IN DETERMINING ITS BIOLOGICAL ACTIVITY ON PANCREATIC ACINIGARDNER JD; WALKER MD; MARTINEZ J et al.1980; BIOCHIM. BIOPHYS. ACTA; NLD; DA. 1980; VOL. 630; NO 3; PP. 323-329; BIBL. 13 REF.Article

Activation of cholecystokinin (CCK₁) and serotonin (5-HT₃) receptors increases the discharge of pancreatic vagal afferentsMUSSA, Bashair M; SARTOR, Daniela M; VERBEME, Anthony J. M et al.European journal of pharmacology. 2008, Vol 601, Num 1-3, pp 198-206, issn 0014-2999, 9 p.Article

Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague-Dawley rats using elevated plus-maze test apparatusFAROOK, J. M; ZHU, Y. Z; WANG, Q et al.Neuroscience letters. 2004, Vol 358, Num 3, pp 215-219, issn 0304-3940, 5 p.Article

THE CCK RECEPTOR ON PANCREATIC PLASMA MEMBRANES: BINDING CHARACTERISTICS AND COVALENT CROSS-LINKINGSAKAMOTO C; WILLIAMS JA; WONG KY et al.1983; FEBS LETTERS; ISSN 0014-5793; NLD; DA. 1983; VOL. 151; NO 1; PP. 63-66; BIBL. 18 REF.Article

THE ASCENT OF CHOLECYSTOKININ (CCK) - FROM GUT TO BRAINMORLEY JE.1982; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1982; VOL. 30; NO 6; PP. 479-493; BIBL. 158 REF.Article

CALCIUM-ACTIVATED AND VOLTAGE-DEPENDEND POTASSIUM CONDUCTANCES IN CLONAL PITUITARY CELLSDUFY B; BARKER JL.1982; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1982; VOL. 30; NO 22; PP. 1933-1941; BIBL. 29 REF.Article

CHOLECYSTOKININ AS SATIETY SIGNALREHFELD JF.1981; INT. J. OBES.; ISSN 0307-0565; GBR; DA. 1981; VOL. 5; NO 5; PP. 465-469; BIBL. 27 REF.Article

CHOLECYSTOKININ REDUCES EXPLORATORY BEHAVIOR IN MICECRAWLEY JN; HAYS SE; PAUL SM et al.1981; PHYSIOL. BEHAV.; ISSN 0031-9384; USA; DA. 1981; VOL. 27; NO 3; PP. 407-411; BIBL. 25 REF.Article

DISTINCT CHOLECYSTOKININ RECEPTORS IN BRAIN AND PANCREASINNIS RB; SNYDER SH.1980; PROC. NATL. ACAD. SCI. U.S.A., BIOL. SCI.; USA; DA. 1980; VOL. 77; NO 11; PP. 6917-6921; BIBL. 33 REF.Article

CHOLECYSTOKININ PEPTIDES IN VITRO MODULATE THE CHARACTERISTICS OF THE STRIATAL ³H-N-PROPYLNORAPOMORPHINE SITESAGNATI LF; CELANI MF; FUXE K et al.1983; ACTA PHYSIOLOGICA SCANDINAVICA; ISSN 0001-6772; SWE; DA. 1983; VOL. 118; NO 1; PP. 79-81; BIBL. 12 REF.Article

Selective CCK-A but not CCK-B receptor antagonists inhibit HT-29 cell proliferation : synergism with pharmacological levels of melatoninGONZALEZ-PUGA, Cristina; GARCIA-NAVARRO, Ana; ESCAMES, Germaine et al.Journal of pineal research. 2005, Vol 39, Num 3, pp 243-250, issn 0742-3098, 8 p.Article

DISTRIBUTION OF CHOLECYSTOKININ-LIKE PEPTIDES IN THE HUMAN BRAINEMSON PC; REHFELD JF; ROSSOR MN et al.1982; J. NEUROCHEM.; ISSN 0022-3042; GBR; DA. 1982; VOL. 38; NO 4; PP. 1177-1179; BIBL. 18 REF.Article

DIBUTYRYL CGMP: INHIBITOR OF THE EFFECT OF CHOLECYSTOKININ AND GASTRIN ON THE GUINEA PIG GALLBLADDER IN VITROPOITRAS P; IACINO D; WALSH JH et al.1980; BIOCHEM. BIOPHYS. RES. COMMUN.; ISSN 0006-291X; USA; DA. 1980; VOL. 96; NO 1; PP. 476-482; BIBL. 7 REF.Article

Morphine analgesia potentiated but tolerance not affected by active immunization against cholecystokininFARIS, P. L; MCLAUGHLIN, C. L; BAILE, C. A et al.Science (Washington, D.C.). 1984, Vol 226, Num 4679, pp 1215-1217, issn 0036-8075Article

CCK-8 modulation of mesolimbic dopamine: antagonism of amphetamine-stimulated behaviorsSCHNEIDER, L. H; ALPERT, J. E; IVERSEN, S. D et al.Peptides (New York, NY. 1980). 1983, Vol 4, Num 5, pp 749-753, issn 0196-9781Article

Cellular expression of CCK-A and CCK-B/gastrin receptors in human gastric mucosaSCHMITZ, Frank; GÖKE, Michael N; SCHMIDT, Wolfgang E et al.Regulatory peptides. 2001, Vol 102, Num 2-3, pp 101-110, issn 0167-0115Article

Further studies on the role of cholecystokinin-A and B receptors in secretion of anterior pituitary hormones in male ratsPEURANEN, E; VASAR, E; KOKS, S et al.Neuropeptides (Edinburgh). 1995, Vol 28, Num 1, pp 1-11, issn 0143-4179Article

Evidence for potentiation by CCK antagonists of the effect of cholecystokinin octapeptide in the elevated plus-mazeVASAR, E; LANG, A; HARRO, J et al.Neuropharmacology. 1994, Vol 33, Num 6, pp 729-735, issn 0028-3908Article

Type A CCK receptors mediate satiety effects of intestinal nutrientsBRENNER, L. A; RITTER, R. C.Pharmacology, biochemistry and behavior. 1996, Vol 54, Num 3, pp 625-631, issn 0091-3057Article